Richard S. Kollender - 17 May 2021 Form 4 Insider Report for Strongbridge Biopharma plc

Role
President and CFO
Signature
/s/ Judith Goldberg, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
17 May 2021
Net transactions value
-$25,974
Form type
4
Filing time
18 May 2021, 19:08:01 UTC
Next filing
14 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SBBP Ordinary Shares Tax liability $25,974 -11,392 -3.5% $2.28 316,108 17 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy taxes payable in connection with the vesting of previously awarded restricted stock units.